Investors expect limited growth for Jiangsu Nhwa Pharmaceuti...

Investors expect limited growth for Jiangsu Nhwa Pharmaceutical, reflected in a low P/E ratio. The inferior earnings outlook compared to the market justifies this lowered P/E. Dismal earnings could further hinder the share price increase.